This grant, offered by a leading health research department, is designed to advance research into innovative screening approaches and therapeutic interventions for conditions affecting newborns. It targets both disorders currently identified through newborn screening and ‘high priority’ genetic conditions where early detection and treatment could significantly improve outcomes. A key purpose of this grant is to develop accurate screening tests and demonstrate the profound benefits of early intervention for these conditions. A ‘high priority’ condition is defined as one not yet routinely screened but where infants would greatly benefit from early identification. This funding aims to ultimately reduce the impact of potentially fatal or disabling conditions in infants by fostering advancements in diagnostics and treatment, ensuring better health outcomes.
Opportunity ID: 357485
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-25-265 |
| Funding Opportunity Title: | Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 – Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.865 — Child Health and Human Development Extramural Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 02, 2024 |
| Last Updated Date: | Dec 02, 2024 |
| Original Closing Date for Applications: | Nov 16, 2027 |
| Current Closing Date for Applications: | Nov 16, 2027 |
| Archive Date: | Dec 22, 2027 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | For profit organizations other than small businesses Independent school districts Public and State controlled institutions of higher education State governments Native American tribal governments (Federally recognized) Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Special district governments Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education City or township governments Private institutions of higher education Public housing authorities/Indian housing authorities County governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | This FOA encourages research relevant to the development of novel screening approaches and/or therapeutic interventions for potentially fatal or disabling conditions that have been identified through newborn screening, as well as for “high priority” genetic conditions where screening may be possible in the near future.Having an accurate screening test, as well as demonstrating the benefits of early intervention or treatment, are important criteria for including a condition on a newborn screening panel. This FOA defines a “high priority” condition as one where screening is not currently recommended, but infants with the condition would significantly benefit from early identification and treatment. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-25-265.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 357485 Full Announcement-PAR-25-265 -> PAR-25-265-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-I | Use for due dates on or after January 25, 2025 | PKG00289321 | Jan 05, 2025 | Nov 16, 2027 | View |
Package 1
Mandatory forms
357485 RR_SF424_5_0-5.0.pdf
357485 PHS398_CoverPageSupplement_5_0-5.0.pdf
357485 RR_OtherProjectInfo_1_4-1.4.pdf
357485 PerformanceSite_4_0-4.0.pdf
357485 RR_KeyPersonExpanded_4_0-4.0.pdf
357485 PHS398_ResearchPlan_5_0-5.0.pdf
357485 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
357485 RR_Budget_3_0-3.0.pdf
357485 RR_SubawardBudget30_3_0-3.0.pdf
357485 PHS398_ModularBudget_1_2-1.2.pdf
357485 PHS_AssignmentRequestForm_4_0-4.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
